<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>As JAK2 V617F, MPL W515L is a novel acquired mutation that induces constitutive cytokine-independent activation of the JAK-STAT pathway in <z:hpo ids='HP_0005547'>myeloproliferative disorders</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MPD</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>The discovery of this mutation provides a novel mechanism for activation of signal transduction in <z:e sem="disease" ids="C0376544" disease_type="Neoplastic Process" abbrv="">hematopoietic malignancies</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>To investigate its prevalence in Chinese patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MPD</z:e>, we introduced allele-specific PCR (AS-PCR) combined with sequence analysis to simultaneously screen MPL W515L and JAK2 V617F mutations in 190 MPD patients </plain></SENT>
<SENT sid="3" pm="."><plain>MPL W515L mutation was found to be harbored in only one of 102 patients, who had <z:e sem="disease" ids="C0040028" disease_type="Disease or Syndrome" abbrv="">essential thrombocythemia</z:e> (ET, 1.0%) and was not detected in patients with <z:hpo ids='HP_0001901'>polycythemia</z:hpo> vera (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e>), idiopathic <z:hpo ids='HP_0011974'>myelofibrosis</z:hpo> (IMF), and <z:hpo ids='HP_0005506'>chronic myelogenous leukemia</z:hpo> (<z:mp ids='MP_0005481'>CML</z:mp>) </plain></SENT>
<SENT sid="4" pm="."><plain>Sixty-eight BCR/ABL-negative <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MPD</z:e> patients (46.3%) were found harboring JAK2 V617F mutation (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e>, 62.5%; ET, 42.1%; IMF 38.1%) </plain></SENT>
<SENT sid="5" pm="."><plain>Furthermore, MPL W515L and JAK2 V617F mutations were not detected in patients of <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo>, <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo>, <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo>, and <z:mp ids='MP_0005481'>CML</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>It has been shown that MPL W515L mutations may contribute to the primary molecular pathogenesis of Chinese patients with ET </plain></SENT>
</text></document>